191 related articles for article (PubMed ID: 35726414)
1. An Extensive Review on β-lactamase Enzymes and their Inhibitors.
Agarwal V; Tiwari A; Varadwaj P
Curr Med Chem; 2023; 30(7):783-808. PubMed ID: 35726414
[TBL] [Abstract][Full Text] [Related]
2. β-lactam antibiotics: An overview from a medicinal chemistry perspective.
Lima LM; Silva BNMD; Barbosa G; Barreiro EJ
Eur J Med Chem; 2020 Dec; 208():112829. PubMed ID: 33002736
[TBL] [Abstract][Full Text] [Related]
3. Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors.
Somboro AM; Osei Sekyere J; Amoako DG; Essack SY; Bester LA
Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 30006399
[TBL] [Abstract][Full Text] [Related]
4. Detailed investigation of catalytically important residues of class A β-lactamase.
Agarwal V; Yadav TC; Tiwari A; Varadwaj P
J Biomol Struct Dyn; 2023 Mar; 41(5):2046-2073. PubMed ID: 34986744
[TBL] [Abstract][Full Text] [Related]
5. Metallo-β-lactamase inhibitors: A continuing challenge for combating antibiotic resistance.
Kang SJ; Kim DH; Lee BJ
Biophys Chem; 2024 Jun; 309():107228. PubMed ID: 38552402
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in β-lactamase inhibitor chemotypes and inhibition modes.
Li R; Chen X; Zhou C; Dai QQ; Yang L
Eur J Med Chem; 2022 Nov; 242():114677. PubMed ID: 35988449
[TBL] [Abstract][Full Text] [Related]
7. β-Lactamases and β-Lactamase Inhibitors in the 21st Century.
Tooke CL; Hinchliffe P; Bragginton EC; Colenso CK; Hirvonen VHA; Takebayashi Y; Spencer J
J Mol Biol; 2019 Aug; 431(18):3472-3500. PubMed ID: 30959050
[TBL] [Abstract][Full Text] [Related]
8. Computational and data mining studies to understand the distribution and dynamics of Temoneria (TEM) β-lactamase and their interaction with β-lactam and β-lactamase inhibitors.
Gehlot P; P H
Environ Pollut; 2022 Dec; 314():120289. PubMed ID: 36180000
[TBL] [Abstract][Full Text] [Related]
9. Evolutionary Trajectories toward High-Level β-Lactam/β-Lactamase Inhibitor Resistance in the Presence of Multiple β-Lactamases.
Rajer F; Allander L; Karlsson PA; Sandegren L
Antimicrob Agents Chemother; 2022 Jun; 66(6):e0029022. PubMed ID: 35652643
[TBL] [Abstract][Full Text] [Related]
10. Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization.
Farhat N; Gupta D; Ali A; Kumar Y; Akhtar F; Kulanthaivel S; Mishra P; Khan F; Khan AU
Microbiol Spectr; 2022 Oct; 10(5):e0045022. PubMed ID: 36069578
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections.
Liu B; Trout REL; Chu GH; McGarry D; Jackson RW; Hamrick JC; Daigle DM; Cusick SM; Pozzi C; De Luca F; Benvenuti M; Mangani S; Docquier JD; Weiss WJ; Pevear DC; Xerri L; Burns CJ
J Med Chem; 2020 Mar; 63(6):2789-2801. PubMed ID: 31765155
[TBL] [Abstract][Full Text] [Related]
12. Progress toward inhibitors of metallo-β-lactamases.
McGeary RP; Tan DT; Schenk G
Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895
[TBL] [Abstract][Full Text] [Related]
13. Resistance to beta-lactam antibiotics: structure and mechanism based design of beta-lactamase inhibitors.
Sandanayaka VP; Prashad AS
Curr Med Chem; 2002 Jun; 9(12):1145-65. PubMed ID: 12052169
[TBL] [Abstract][Full Text] [Related]
14. Exploring the potential of boronic acids as inhibitors of OXA-24/40 β-lactamase.
Werner JP; Mitchell JM; Taracila MA; Bonomo RA; Powers RA
Protein Sci; 2017 Mar; 26(3):515-526. PubMed ID: 27997706
[TBL] [Abstract][Full Text] [Related]
15. β-Lactams and β-Lactamase Inhibitors: An Overview.
Bush K; Bradford PA
Cold Spring Harb Perspect Med; 2016 Aug; 6(8):. PubMed ID: 27329032
[TBL] [Abstract][Full Text] [Related]
16. Designing Inhibitors of β-Lactamase Enzymes to Overcome Carbapenem Resistance in Gram-Negative Bacteria.
Davies DT; Everett M
Acc Chem Res; 2021 May; 54(9):2055-2064. PubMed ID: 33788541
[TBL] [Abstract][Full Text] [Related]
17. Cyclic Boronates Inhibit All Classes of β-Lactamases.
Cahill ST; Cain R; Wang DY; Lohans CT; Wareham DW; Oswin HP; Mohammed J; Spencer J; Fishwick CW; McDonough MA; Schofield CJ; Brem J
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115348
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial and β-Lactamase Inhibitory Activity of Monocyclic β-Lactams.
Decuyper L; Jukič M; Sosič I; Žula A; D'hooghe M; Gobec S
Med Res Rev; 2018 Mar; 38(2):426-503. PubMed ID: 28815732
[TBL] [Abstract][Full Text] [Related]
19. Efforts towards the inhibitor design for New Delhi metallo-beta-lactamase (NDM-1).
Nagulapalli Venkata KC; Ellebrecht M; Tripathi SK
Eur J Med Chem; 2021 Dec; 225():113747. PubMed ID: 34391033
[TBL] [Abstract][Full Text] [Related]
20. Designing of inhibitors against CTX-M-15 type β-lactamase: potential drug candidate against β-lactamases-producing multi-drug-resistant bacteria.
Ali A; Danishuddin ; Maryam L; Srivastava G; Sharma A; Khan AU
J Biomol Struct Dyn; 2018 May; 36(7):1806-1821. PubMed ID: 28545327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
